Using 3D organoid cultures, we performed a synthetic lethal screen of splicing factors altered in CRC, identifying the splicing factor SRSF1 as a therapeutic vulnerability in CRC organoids. The gene discussed is SRSF1; the disease is colorectal carcinoma.